Login
Contact
May 27, 2026

Explore expert insights, strategic thinking, and real-world advice in our blog.
Share Now:

NEUP: a microcap name on my radar because Lynx1 (16% hds) bid $4.75 in late ’25:

Neuphoria Therapeutics Inc.: 8-K: ” … Based on past program contributions, Neuphoria believes it is eligible to receive approximately 4.65% of future milestone payments, if any, from CTXT, of which the total value to all 17 parties (see below) combined is estimated to be USD$460M …”

NEUP basically saying they are “eligible for” > $21mm (mrkt cap $29mm)

Related Posts

Stay current on weekly positioning reports, regime shifts, and updated data across equities, rates, FX, and commodities.
All rights reserved. RBJR LLC 2026
  • Based In North Carolina
Disclaimer: This publication is for general informational and educational purposes only. It is not investment advice, does not take into account individual circumstances, and should not be relied upon for making investment decisions. The views expressed are solely those of the author and do not represent the views of any employer or affiliated institution.
Two weeks of the Basic Plan, the weekly Positioning Report and the Asset-Class Matrix.

Stay Current on Positioning Intelligence

Sign up to receive Rick's weekly reports and updated positioning data straight to your inbox.
Fill out the form for complimentary access to the Offsides Macro Positioning Suite, including the weekly macro deck and the full interactive positioning analytics dashboard. Foundational access period. This will transition to subscriber access.